133544-77-1

Basic information

• Product Name: 3-(3',6'-dioxo-2',4'-dimethylcyclohexa-1',4'-diene)-3,3-dimethylpropionic acid
• Synonyms: 3-(3',6'-dioxo-2',4'-dimethylcyclohexa-1',4'-diene)-3,3-dimethylpropionic acid
• CAS NO: 133544-77-1
• Molecular Formula: C₁₃H₁₆O₄
• Molecular Weight: 236.26374
• Mol File: 133544-77-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 373.3°Cat760mmHg
• Flash Point: 193.7°C
• Appearance: /
• Density: 1.197g/cm³
• CAS DataBase Reference: 3-(3',6'-dioxo-2',4'-dimethylcyclohexa-1',4'-diene)-3,3-dimethylpropionic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3',6'-dioxo-2',4'-dimethylcyclohexa-1',4'-diene)-3,3-dimethylpropionic acid(133544-77-1)
• EPA Substance Registry System: 3-(3',6'-dioxo-2',4'-dimethylcyclohexa-1',4'-diene)-3,3-dimethylpropionic acid(133544-77-1)

Safety Data

• Hazardous Substances Data: 133544-77-1(Hazardous Substances Data)

Upstream product

• 527-61-7 2,6-dimethyl-1,4-benzoquinone 
• 654-42-2 1,4-dihydroxy-2,6-dimethylbenzene 
• 265645-65-6 (S)-3-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-2-[3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyrylamino]-propionic acid methyl ester 
• 50442-68-7 6-hydroxy-4,4,5,7-tetramethyl-3,4-dihydrocoumarin 

Downstream Products

• 50442-68-7 6-hydroxy-4,4,5,7-tetramethyl-3,4-dihydrocoumarin 
• 143859-68-1 3-(3',6'-Dioxo-2',4'-dimethylcyclohexa-1',4'-dienyl)-3,3-dimethylpropanoic acid N-(p-methoxyphenyl)amide 
• 244108-31-4 tert-butyl 3-methyl-3-(3,5-dimethyl-1,4-benzoquinonyl)butyrate 
• 182122-29-8 4,4,2',4'-Tetramethyl-1-(p-methoxyphenyl)-1-azaspiro<4.1'>dec-4'-ene-2,3',6'-trione 
• 265645-65-6 (S)-3-{4-[Bis-(2-chloro-ethyl)-amino]-phenyl}-2-[3-(2,4-dimethyl-3,6-dioxo-cyclohexa-1,4-dienyl)-3-methyl-butyrylamino]-propionic acid methyl ester 

Relevant articles and documents

NQO1-activated 6 -diazyl -5 - oxo - L -n-leucine prodrug and preparation method and application thereof

The invention discloses NQO1-activated 6 -diazyl -5 - oxo - L - n-leucine prodrug and a preparation method and application thereof. Due to the high expression NQO1 in most tumor cells, the introduced NQO1 activated quinic acid group can achieve the tumor

Anti-tumuor agents

The invention concerns anti-tumour agents of formula (I) wherein each of R1, R2and R3has the meanings defined in the specification including hydrogen, (1-4C)alkyl, (3-4)alkenyl, (3-4C)alkynyl, amino, (1-4C)alkylamino and (

Reductive activation of conformationally-constrained, anticancer drug delivery systems

Redox-active substituents were used to modulate reduction potentials in conformationally-constrained, drug delivery systems. The extent of drug delivery was proportional to the degree of reductive activation, which was influenced by the electronic properties of the substituents. Such reductively-activated carrier systems can be used to achieve controlled drug delivery to bioreductive regions in hypoxic solid tumors.